|
|
1475 N Broadway, Suite 400
Walnut Creek, CA 94596 USA
phone:916.55.6820
fax:415.762.5487
|
|
| Symbol |
private |
| Founded |
0 |
| Employees |
|
|
|
| sanovas.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Interventional Pulmonary devices. |
|
| Management |
| Larry Gerrans ? President & CEO
Erhan Gunday ? Chief Technology Officer |
| |
|
|
| |
|
| Keywords |
| Lung, Cancer, Device, pulmonary catheters, COPD |
|
|
|
| Description |
|
Sanovas Surgical Technologies is excited to introduce its revolutionary ‘Smart Catheter’ technology – The Vas Zeppelin™. Sanovas technology significantly advances minimally invasive surgery through advanced visualization and physiologic measurement systems that operate within new sensory guided interventional catheters to provide innovative navigation, treatment, resection and the point specific delivery and application of drug and immune therapies; creating an innovative new solution that is poised to become the standard of care in the Interventional Pulmonary Science.
Sanovas is expected to grow significantly in the next five years as its solutions address the unmet needs of the interventional pulmonary science by evolving a very expensive & risky surgery (airway obstruction) into an out-patient procedure that will now be able to be performed by more community based doctors. Highlights include: |
|
| Products / Services |
A Revolutionary First to Market Smart Catheter Technology.
The only 360 Non Thermal Re-Cannulization Technology available!
Can be performed via Rigid or Flexible Bronchoscopy
Procedure can be done with pure oxygen no mixed gases ; improved O2 SAT.
Controlled operative environment. Reduced patient distress.
No flash hazard; No thermal necrosis.
Resected tissue isolated to the operative area.
Physiologic Metrics reduce likelihood of patient injury, complications
Controls: Hypoxia; Postobstructive Pneumonia; Atelectasis; Hemoptysis.
Homeostasis with Balloon Tamponade.
Complete Bronchus & Segmental Bronchi desobstruction.
Submucosal & submural tumor resection.
|
|
| Technology / Differentiation |
| The technology portfolio has been developed to provide the surgeon an intelligent system of tools to provide simple, reproducible methods that improve surgical skill and accuracy. For the first time in the history of Endo- Bronchial treatment, the Sanovas portfolio of technologies will make 360° treatment and intervention possible in the trachea, main bronchi, superior lobe and segmental bronchi in a safe, efficient and simple method. These technologies employ Proprietary Diagnostic & Treatment solutions in the forms of:
Micro-Imaging
Physiologic Metrics
Access
Resection
Drug Delivery |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members